REGULATORY AFFAIRS AND GLOBAL HARMONIZATION IN PHARMACEUTICAL INDUSTRY

View at publisher Summarise with VIRAT
Authors: Vyanktesh S. Lakde, Bhagyashri O. Fate, Suraj D. Thakare Thakare, Shital D. Patil
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Regulatory affairs play a vital role in ensuring that pharmaceutical products meet the required standards of safety, efficacy, and quality throughout their development and marketing lifecycle. With the rapid globalization of the pharmaceutical industry, the need for harmonized regulatory systems has become increasingly important. Regulatory affairs professionals navigate diverse international guidelines, prepare regulatory submissions, ensure compliance with Good Manufacturing Practices (GMP), and maintain communication between regulatory authorities and industry. Global harmonization aims to align technical requirements, reduce duplication of testing, simplify approval pathways, and accelerate patient access to quality medicines worldwide. Global organizations including the International Council for Harmonisation (ICH), World Health Organization (WHO), and Pharmaceutical Inspection Co-operation Scheme (PIC/S) have established harmonized guidelines covering quality, safety, efficacy, and inspection procedures. These harmonization initiatives promote consistency across major markets such as the United States, Europe, and Japan, and support regulatory strengthening in developing regions. Benefits of global harmonization include enhanced regulatory efficiency, improved transparency, better supply chain management, and greater innovation through predictable regulatory frameworks. Despite progress, challenges such as differing national regulations, infrastructural limitations, and varied healthcare priorities continue to hinder complete global alignment. Ongoing international collaboration, capacity-building, and adoption of digital regulatory tools remain essential to achieving robust and efficient global harmonization. Overall, regulatory affairs and harmonized standards significantly contribute to safeguarding public health and supporting sustainable pharmaceutical innovation.

Fields of Study & Subjects

Healthcare Regulation Biomedical Ethics and Regulation Pharmaceutical Economics and Policy

Publication details

Journal / source
Iterative International Publishers eBooks
Pages
192–207
Publication date
1 January 2026
Language
EN
Document type
Book chapter